Skip to content

Clinical study of dorsal root ganglion stimulation for the treatment of neuropathic pain

Clinical study of dorsal root ganglion stimulation for the treatment of neuropathic pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099318
Enrollment
Unknown
Registered
2025-03-21
Start date
2025-02-06
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster-associated neuralgia

Interventions

Dorsal root ganglion electrical stimulation group:dorsal root ganglion stimulation

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old; 2. Clinical diagnosis of neuropathic pain; 3. The course of the disease > = 3 months, NRS > = 6 points, and the pain is distributed along the thoracic, lumbar and/or sacral vertebrae; 4. Drugs in the past, nerve block or radiofrequency and other treatments with poor analgesic effect; 5. If receiving medication, it needs to be used stably for 4 weeks or more; 6. The subject or his/her legal representative signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Alcoholism or drug dependence; 3. DRGS-related contraindications include but are not limited to severe coagulation dysfunction, heart, liver and kidney insufficiency, bedsores in the area to be operated, local infection, etc.; 4. History of malignant tumors; 5. Combined with mental illness such as somatization disorder; 6. Unwilling to undergo treatment or follow-up evaluation; 7. Participated in other clinical trials within 3 months prior to enrollment in this clinical trial; 8. There are other situations that the investigator considers unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
The MOS item short fromhealth survey, SF-36;Hamilton Depression Scale, HAMD;Hamilton Anxiety Scale, HAMA;EQ-5D,EuroQol Five Dimensions Questionnaire;Pittsburgh sleep quality index, PSQI;

Countries

China

Contacts

Public ContactZhu Hongwei

Xuanwu Hospital Capital Medical University

zhuhongwei@xwh.ccmu.edu.cn+86 136 6134 9255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026